{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:10:43Z","timestamp":1753884643813,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00405-021-06750-4","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T19:38:11Z","timestamp":1616096291000},"page":"4147-4154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Non-aesthetic uses of botulinum toxin in the head and neck"],"prefix":"10.1007","volume":"278","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0839-3094","authenticated-orcid":false,"given":"Natalie Anne","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohaib","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin John","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakubu","family":"Karagama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Gibbins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"1","key":"6750_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3928\/0191-3913-19800101-06","volume":"17","author":"AB Scott","year":"1980","unstructured":"Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J PediatrOphthalmol Strabismus 17(1):21\u201325","journal-title":"J PediatrOphthalmol Strabismus"},{"issue":"2","key":"6750_CR2","first-page":"353","volume":"84","author":"RP Clark","year":"1989","unstructured":"Clark RP, Berris CE (1989) Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. PlastReconstrSurg 84(2):353\u2013355","journal-title":"PlastReconstrSurg"},{"key":"6750_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004314.pub3","author":"GSCM Duarte","year":"2016","unstructured":"Duarte GSCM, Rodrigues FB, Marques RE, Ferreira J, Sampaio C, Moore AP, Costa J (2016) Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004314.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"6750_CR4","first-page":"77","volume":"33","author":"H Jinnah","year":"2015","unstructured":"Jinnah H, Factor SA (2015) Diagnosis and treatment of dystonia. NeurolClin 33(1):77\u2013100","journal-title":"NeurolClin"},{"issue":"4","key":"6750_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.otohns.2008.05.624","volume":"139","author":"CL Ludlow","year":"2008","unstructured":"Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB et al (2008) Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 139(4):495\u2013505","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"2","key":"6750_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0194599816675320","volume":"156","author":"BF van Esch","year":"2017","unstructured":"van Esch BF, Wegner I, Stegeman I, Grolman W (2017) Effect of botulinum toxin and surgery among spasmodic dysphonia patients: a systematic review. Otolaryngol Head Neck Surg 156(2):238\u2013254","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"6750_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1097\/00005537-199810000-00003","volume":"108","author":"A Blitzer","year":"1998","unstructured":"Blitzer A, Brin MF, Stewart CF (1998) Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 108(10):1435\u20131441","journal-title":"Laryngoscope"},{"key":"6750_CR8","first-page":"203","volume-title":"Spasmodic dysphonia","author":"T Meyer","year":"2006","unstructured":"Meyer T, Blitzer A (2006) Spasmodic dysphonia. CRC Press, Handbook of dystonia, pp 203\u2013212"},{"issue":"3","key":"6750_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12165","volume":"42","author":"OH Ababneh","year":"2014","unstructured":"Ababneh OH, Cetinkaya A, Kulwin DR (2014) Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clin Experiment Ophthalmol 42(3):254\u2013261","journal-title":"Clin Experiment Ophthalmol"},{"key":"6750_CR10","doi-asserted-by":"publisher","unstructured":"Costa J, Esp\u00edrito\u2010Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev (1):CD003633. https:\/\/doi.org\/10.1002\/14651858.CD003633.pub2","DOI":"10.1002\/14651858.CD003633.pub2"},{"key":"6750_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.toxicon.2018.02.006","volume":"147","author":"CL Comella","year":"2018","unstructured":"Comella CL (2018) Systematic review of botulinum toxin treatment for oromandibular dystonia. Toxicon 147:96\u201399","journal-title":"Toxicon"},{"issue":"6","key":"6750_CR12","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/toxins7062321","volume":"7","author":"CHF Camargo","year":"2015","unstructured":"Camargo CHF, Cattai L, Teive HAG (2015) Pain relief in cervical dystonia with botulinum toxin treatment. Toxins 7(6):2321\u20132335","journal-title":"Toxins"},{"key":"6750_CR13","volume-title":"A textbook of head and neck anatomy","author":"BK Berkovits","year":"1988","unstructured":"Berkovits BK, Moxham BJ (1988) A textbook of head and neck anatomy. Mosby, Incorporated, London"},{"issue":"S8","key":"6750_CR14","first-page":"S109","volume":"19","author":"J Jankovic","year":"2004","unstructured":"Jankovic J (2004) Treatment of cervical dystonia with botulinum toxin. MovDisord 19(S8):S109\u2013S115","journal-title":"MovDisord"},{"issue":"6","key":"6750_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1468-1331.2000.00161.x","volume":"7","author":"D Dressler","year":"2000","unstructured":"Dressler D (2000) Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 7(6):713\u2013718","journal-title":"Eur J Neurol"},{"issue":"3","key":"6750_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249\u2013263","journal-title":"N Engl J Med"},{"key":"6750_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413487610","volume-title":"ICHD-3 beta is published. Use it immediately","author":"J Olesen","year":"2013","unstructured":"Olesen J (2013) ICHD-3 beta is published. Use it immediately. Sage Publications, London, England"},{"issue":"7","key":"6750_CR18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"H Diener","year":"2010","unstructured":"Diener H, Dodick DW, Aurora S, Turkel C, DeGryse R, Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804\u2013814","journal-title":"Cephalalgia"},{"issue":"18","key":"6750_CR19","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1111\/bph.12763","volume":"171","author":"R Ramachandran","year":"2014","unstructured":"Ramachandran R, Yaksh TL (2014) Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol 171(18):4177\u20134192","journal-title":"Br J Pharmacol"},{"issue":"1","key":"6750_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-016-0591-3","volume":"17","author":"A Negro","year":"2015","unstructured":"Negro A, Curto M, Lionetto L, Martelletti P (2015) A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience. J Headache Pain 17(1):1","journal-title":"J Headache Pain"},{"issue":"1","key":"6750_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1526-4610.2010.01796.x","volume":"51","author":"RK Cady","year":"2011","unstructured":"Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU (2011) A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. Headache J Head Face Pain. 51(1):21\u201332","journal-title":"Headache J Head Face Pain."},{"issue":"2","key":"6750_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/lary.22404","volume":"122","author":"R Filipo","year":"2012","unstructured":"Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA (2012) Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope 122(2):266\u2013270","journal-title":"Laryngoscope"},{"issue":"12","key":"6750_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1503\/cmaj.131801","volume":"186","author":"JR de Almeida","year":"2014","unstructured":"de Almeida JR, Guyatt GH, Sud S, Dorion J, Hill MD, Kolber MR et al (2014) Management of Bell palsy: clinical practice guideline. CMAJ 186(12):917\u2013922","journal-title":"CMAJ"},{"issue":"4","key":"6750_CR24","first-page":"917","volume":"120","author":"M de Maio","year":"2007","unstructured":"de Maio M, Bento RF (2007) Botulinum toxin in facial palsy: an effective treatment for contralateral hyperkinesis. PlastReconstrSurg 120(4):917\u2013927","journal-title":"PlastReconstrSurg"},{"issue":"4","key":"6750_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamafacial.2015.0399","volume":"17","author":"N Jowett","year":"2015","unstructured":"Jowett N, Hadlock TA (2015) A contemporary approach to facial reanimation. JAMA Facial PlastSurg 17(4):293\u2013300","journal-title":"JAMA Facial PlastSurg"},{"issue":"1","key":"6750_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0194599811424125","volume":"146","author":"T Azuma","year":"2012","unstructured":"Azuma T, Nakamura K, Takahashi M, Ohyama S, Toda N, Iwasaki H et al (2012) Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Otolaryngol Head Neck Surg 146(1):40\u201345","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"6750_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/PRS.0000000000000800","volume":"135","author":"AF do NascimentoRemigio","year":"2015","unstructured":"do NascimentoRemigio AF, Salles AG, de Faria JCM, Ferreira MC (2015) Comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA at the 1:3 conversion ratio for the treatment of asymmetry after long-term facial paralysis. PlastReconstr Surg. 135(1):239\u2013249","journal-title":"PlastReconstr Surg."},{"issue":"1","key":"6750_CR28","first-page":"11","volume":"24","author":"OB Mehdizadeh","year":"2016","unstructured":"Mehdizadeh OB, Diels J, White WM (2016) Botulinum toxin in the treatment of facial paralysis. Facial PlastSurgClin 24(1):11\u201320","journal-title":"Facial PlastSurgClin"},{"issue":"8","key":"6750_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3109\/00016489.2011.577447","volume":"131","author":"S Monini","year":"2011","unstructured":"Monini S, De Carlo A, Biagini M, Buffoni A, Volpini L, Lazzarino AI et al (2011) Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol 131(8):882\u2013886","journal-title":"Acta Otolaryngol"},{"key":"6750_CR30","first-page":"305","volume-title":"Rehabilitation after total laryngectomy. Scott-Brown's Otorhinolaryngology and Head and Neck Surgery","author":"Y Edels","year":"2018","unstructured":"Edels Y, Clarke P (2018) Rehabilitation after total laryngectomy. Scott-Brown\u2019s Otorhinolaryngology and Head and Neck Surgery. CRC Press, Boca Raton, pp 305\u2013314"},{"issue":"6","key":"6750_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.amjoto.2008.07.008","volume":"30","author":"E Krause","year":"2009","unstructured":"Krause E, Hempel J-M, G\u00fcrkov R (2009) Botulinum toxin A prolongs functional durability of voice prostheses in laryngectomees with pharyngoesophageal spasm. Am J Otolaryngol 30(6):371\u2013375","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"6750_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1017\/S0022215100123345","volume":"107","author":"P Scott","year":"1993","unstructured":"Scott P, Bleach N, Perry A, Cheesman A (1993) Complications of pharyngeal myotomy for alaryngeal voice rehabilitation. J LaryngolOtol 107(5):430\u2013433","journal-title":"J LaryngolOtol"},{"issue":"12","key":"6750_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1017\/S0022215109990430","volume":"123","author":"S Khemani","year":"2009","unstructured":"Khemani S, Govender R, Arora A, O\u2019Flynn P, Vaz F (2009) Use of botulinum toxin in voice restoration after laryngectomy. J LaryngolOtol 123(12):1308\u20131313","journal-title":"J LaryngolOtol"},{"issue":"3","key":"6750_CR34","first-page":"173","volume":"103","author":"DJ Halvorson","year":"1994","unstructured":"Halvorson DJ, Kuhn FA (1994) Transmucosal cricopharyngeal myotomy with the potassium-titanyl-phosphate laser in the treatment of cricopharyngeal dysmotility. Ann OtolRhinolLaryngol 103(3):173\u2013177","journal-title":"Ann OtolRhinolLaryngol"},{"issue":"1","key":"6750_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/lary.25447","volume":"126","author":"P Kocdor","year":"2016","unstructured":"Kocdor P, Siegel ER, Tulunay-Ugur OE (2016) Cricopharyngeal dysfunction: a systematic review comparing outcomes of dilatation, botulinum toxin injection, and myotomy. Laryngoscope 126(1):135\u2013141","journal-title":"Laryngoscope"},{"issue":"8","key":"6750_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.gassur.2004.09.037","volume":"8","author":"G Zaninotto","year":"2004","unstructured":"Zaninotto G, Ragona RM, Briani C, Costantini M, Rizzetto C, Portale G et al (2004) The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia. J GastrointestSurg 8(8):997\u20131006","journal-title":"J GastrointestSurg"},{"key":"6750_CR37","doi-asserted-by":"publisher","DOI":"10.11152\/mu-2097","author":"Y-C Wang","year":"2019","unstructured":"Wang Y-C, Wu C-H, Shyu S-G, Hsiao M-Y, Wang T-G (2019) Ultrasonography-guided botulinum toxin injection to the cricopharyngeus muscle: a case report and technical notes. Med Ultrason. https:\/\/doi.org\/10.11152\/mu-2097","journal-title":"Med Ultrason"},{"issue":"8","key":"6750_CR38","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1001\/archotol.1990.01870080032009","volume":"116","author":"J Elidan","year":"1990","unstructured":"Elidan J, Shochina M, Gonen B, Gay I (1990) Manometry and electromyography of the pharyngeal muscles in patients with dysphagia. Arch Otolaryngol Head Neck Surg 116(8):910\u2013913","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"6750_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S0022215119000124","volume":"133","author":"K Lau","year":"2019","unstructured":"Lau K, Watson M (2019) Pharyngeal pouch: comparison of surgical treatment with botulinum toxin injection to the cricopharyngeus. J LaryngolOtol 133(2):125\u2013128","journal-title":"J LaryngolOtol"},{"issue":"1","key":"6750_CR40","doi-asserted-by":"publisher","first-page":"2473974X1983455","DOI":"10.1177\/2473974X19834553","volume":"3","author":"RW Bastian","year":"2019","unstructured":"Bastian RW, Smithson ML (2019) Inability to Belch and associated symptoms due to retrograde cricopharyngeus dysfunction: diagnosis and treatment. OTO open. 3(1):2473974X19834553","journal-title":"OTO open."},{"issue":"5","key":"6750_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/jnnp.67.5.697","volume":"67","author":"K Bhatia","year":"1999","unstructured":"Bhatia K, M\u00fcnchau A, Brown P (1999) Botulinum toxin is a useful treatment in excessive drooling of saliva. J NeurolNeurosurg Psychiatry. 67(5):697","journal-title":"J NeurolNeurosurg Psychiatry."},{"issue":"17","key":"6750_CR42","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","volume":"92","author":"WH Jost","year":"2019","unstructured":"Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A et al (2019) SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea. Neurology 92(17):e1982\u2013e1991","journal-title":"Neurology"},{"key":"6750_CR43","first-page":"12","volume":"51","author":"K Sridharan","year":"2018","unstructured":"Sridharan K, Sivaramakrishnan G (2018) Pharmacological interventions for treating sialorrhea associated with neurological disorders: a mixed treatment network meta-analysis of randomized controlled trials. J ClinNeurosci 51:12\u201317","journal-title":"J ClinNeurosci"},{"issue":"5","key":"6750_CR44","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/lio2.306","volume":"4","author":"AT Schwalje","year":"2019","unstructured":"Schwalje AT, Hoffman HT (2019) Intraductal Salivary Gland Infusion With Botulinum Toxin. Laryngoscope InvestigOtolaryngol 4(5):520\u2013525","journal-title":"Laryngoscope InvestigOtolaryngol"},{"issue":"2","key":"6750_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/lary.27416","volume":"129","author":"T Send","year":"2019","unstructured":"Send T, Bertlich M, Eichhorn KW, Bootz F, Jakob M (2019) Management and follow-up results of salivary fistulas treated with botulinum toxin. Laryngoscope 129(2):403\u2013408","journal-title":"Laryngoscope"},{"issue":"4","key":"6750_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10006-012-0375-0","volume":"17","author":"R Laskawi","year":"2013","unstructured":"Laskawi R, Winterhoff J, K\u00f6hler S, Kottwitz L, Matthias C (2013) Botulinum toxin treatment of salivary fistulas following parotidectomy: follow-up results. Oral MaxillofacSurg 17(4):281\u2013285","journal-title":"Oral MaxillofacSurg"},{"issue":"3","key":"6750_CR47","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/hed.24629","volume":"39","author":"K Mantsopoulos","year":"2017","unstructured":"Mantsopoulos K, Scherl C, Iro H (2017) Investigation of arguments against properly indicated extracapsular dissection in the parotid gland. Head Neck 39(3):498\u2013502","journal-title":"Head Neck"},{"issue":"2","key":"6750_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00106-010-2223-6","volume":"59","author":"A Neumann","year":"2011","unstructured":"Neumann A, Rosenberger D, Vorsprach O, Dazert S (2011) The incidence of Frey syndrome following parotidectomy: results of a survey and follow-up. HNO 59(2):173\u2013178","journal-title":"HNO"},{"issue":"3","key":"6750_CR49","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/00016489509139348","volume":"115","author":"C Drobik","year":"1995","unstructured":"Drobik C, Laskawi R (1995) Frey\u2019s syndrome: treatment with botulinum toxin. Acta Otolaryngol 115(3):459\u2013461","journal-title":"Acta Otolaryngol"},{"issue":"11","key":"6750_CR50","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/cam4.504","volume":"4","author":"S Xie","year":"2015","unstructured":"Xie S, Wang K, Xu T, Guo XS, Shan XF, Cai ZG (2015) Efficacy and safety of botulinum toxin type A for treatment of Frey\u2019s syndrome: evidence from 22 published articles. Cancer Med 4(11):1639\u20131650","journal-title":"Cancer Med"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-06750-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-021-06750-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-021-06750-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T05:18:17Z","timestamp":1633065497000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-021-06750-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6750"],"URL":"https:\/\/doi.org\/10.1007\/s00405-021-06750-4","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"type":"print","value":"0937-4477"},{"type":"electronic","value":"1434-4726"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review article does not involve research with human participants and\/or animals and thus informed consent was not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}